N,N′-Alkane-diyl-bis-3-picoliniums as Nicotinic Receptor Antagonists: Inhibition of Nicotine-induced Dopamine Release and Hyperactivity

Documenti analoghi

• The Novel Nicotinic Receptor Antagonist, N,N′-Dodecane-1,12-diyl-bis-3-picolinium Dibromide (bPiDDB), Inhibits Nicotine-evoked [(3)H]Norepinephrine Overflow from Rat Hippocampal Slices
  di: Smith, Andrew M., et al.
  Pubblicazione: (2009)
• Region-specific effects of N,N′-dodecane-1,12-diyl-bis-3-picolinium dibromide on nicotine-induced increase in extracellular dopamine in vivo
  di: Rahman, S, et al.
  Pubblicazione: (2008)
• The novel nicotinic receptor antagonist N,N′-dodecane-1,12-diyl-bis-3-picolinium dibromide decreases nicotine-induced dopamine metabolism in rat nucleus accumbens
  di: Rahman, Shafiqur, et al.
  Pubblicazione: (2008)
• Discovery of a novel nicotinic receptor antagonist for the treatment of nicotine addiction: 1-(3-picolinium)-12-triethylammonium-dodecane dibromide (TMPD)
  di: Dwoskin, Linda P., et al.
  Pubblicazione: (2007)
• tris-Azaaromatic quaternary ammonium salts: novel templates as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release
  di: Zheng, Guangrong, et al.
  Pubblicazione: (2007)